ErbB2 is a receptor tyrosine kinase overexpressed in 25% to 30% of human breast cancers, drives mammary tumor formation, and defines the HER2 subtype, a poor-prognosis form of breast cancer [17]. This evidence concerns the gene NTRK1 and breast cancer.